EQS-News: Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19
EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19 19.08.2021 / 07:00 Relief Reports...
United Kingdom Michael Miller Jack Weinstein Advita Lifescience Gmb National Institutes Of Health Pharma Research
Source: boersennews.de